Literature DB >> 9720119

Auditory hallucinations: a review of psychological treatments.

S S Shergill1, R M Murray, P K McGuire.   

Abstract

Auditory hallucinations (AH) occur frequently amongst psychiatric patients, being most common in schizophrenia. In 25-30% of cases they are refractory to traditional antipsychotic drugs. A variety of psychosocial treatments have been used, but their efficacy remains unclear. This review aims to bring together the more recent studies of psychological treatments and discuss them in the context of recent cognitive models of hallucinations and functional imaging studies. The search strategy included the following sources: MEDLINE, Embase and Psychlit. Strategies reported by patients can be categorised as: (1) distracting activities, such as listening to music; (2) behavioural tasks, such as taking exercise; (3) cognitive tasks, such as ignoring AH. Almost all the strategies produced some benefit in some patients: treatment often improved AH-associated distress, rather than frequency of AH. There are many difficulties in conducting research on AH. Treatment should be individually tailored and used as an adjunct to pharmacotherapy. Future theory-driven studies need to be based on complex aetiological models and incorporate functional imaging to elucidate the physiological changes induced by therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9720119     DOI: 10.1016/s0920-9964(98)00052-8

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  64 in total

1.  Taking back the brain: could neurofeedback training be effective for relieving distressing auditory verbal hallucinations in patients with schizophrenia?

Authors:  Simon McCarthy-Jones
Journal:  Schizophr Bull       Date:  2012-02-09       Impact factor: 9.306

Review 2.  The brain, language, and schizophrenia.

Authors:  Mahendra T Bhati
Journal:  Curr Psychiatry Rep       Date:  2005-08       Impact factor: 5.285

3.  Neuromodulation Treatments for Schizophrenia.

Authors:  Mehmet E Dokucu
Journal:  Curr Treat Options Psychiatry       Date:  2015-07-03

4.  Cerebellar Contributions to Persistent Auditory Verbal Hallucinations in Patients with Schizophrenia.

Authors:  Maximilian Cierpka; Nadine D Wolf; Katharina M Kubera; Mike M Schmitgen; Nenad Vasic; Karel Frasch; Robert Christian Wolf
Journal:  Cerebellum       Date:  2017-12       Impact factor: 3.847

Review 5.  Do we need multiple models of auditory verbal hallucinations? Examining the phenomenological fit of cognitive and neurological models.

Authors:  Simon R Jones
Journal:  Schizophr Bull       Date:  2008-09-26       Impact factor: 9.306

Review 6.  Hallucinations and Strong Priors.

Authors:  Philip R Corlett; Guillermo Horga; Paul C Fletcher; Ben Alderson-Day; Katharina Schmack; Albert R Powers
Journal:  Trends Cogn Sci       Date:  2018-12-21       Impact factor: 20.229

Review 7.  [Cognitive control in the research domain criteria system: clinical implications for auditory verbal hallucinations].

Authors:  Katharina M Kubera; Dusan Hirjak; Nadine D Wolf; Robert C Wolf
Journal:  Nervenarzt       Date:  2021-08-03       Impact factor: 1.214

8.  Transcranial magnetic stimulation of Wernicke's and Right homologous sites to curtail "voices": a randomized trial.

Authors:  Ralph E Hoffman; Kun Wu; Brian Pittman; John D Cahill; Keith A Hawkins; Thomas Fernandez; Jonas Hannestad
Journal:  Biol Psychiatry       Date:  2013-02-26       Impact factor: 13.382

9.  Theta Burst Transcranial Magnetic Stimulation for Auditory Verbal Hallucinations: Negative Findings From a Double-Blind-Randomized Trial.

Authors:  Sanne Koops; Edwin van Dellen; Maya J L Schutte; Wendy Nieuwdorp; Sebastiaan F W Neggers; Iris E C Sommer
Journal:  Schizophr Bull       Date:  2015-07-28       Impact factor: 9.306

10.  Neurological Soft Signs Predict Auditory Verbal Hallucinations in Patients With Schizophrenia.

Authors:  Robert C Wolf; Mahmoud Rashidi; Mike M Schmitgen; Stefan Fritze; Fabio Sambataro; Katharina M Kubera; Dusan Hirjak
Journal:  Schizophr Bull       Date:  2021-03-16       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.